SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Novel Drug Delivery Systems to Treat Mild Traumatic Brain Injury Based on Carbon Nanotubes, University of Texas Health Science Center, University of Texas Medical Branch, Baylor College of Medicine, Rice University and Transitional Learning Center
August 25, 2008
 · 
1 min read
Lone Star Bio
Molecule That Keeps Pathogens Like Salmonella In Check Uncovered, University of Texas Southwestern Medical Center Study; New Antibiotic May Block Toxins From Bacteria
August 22, 2008
 · 
1 min read
Lone Star Bio
Researchers Uncover Attack Mechanism Of Illness-inducing Bacterium, University of Texas Southwestern Medical Center Study
August 20, 2008
 · 
1 min read
Drug Development
Eli Lilly and Company Impotence Drug Treats Prostate Enlargement, University of Texas Southwestern Medical Center and Northwestern University Study
August 19, 2008
 · 
1 min read
Lone Star Bio
Model For Neurological Disorder ‘Angelman Syndrome’ Developed, University of Texas Study
August 15, 2008
 · 
1 min read
Lone Star Bio
Sensitivity To Antidepressants Linked With Trkb-Mediated Neural Proliferation, University of Texas Southwestern Medical Center Study
August 14, 2008
 · 
1 min read
Lone Star Bio
Tiny Molecule Helps Control Blood-vessel Development, University of Texas Southwestern Medical Center Study
August 13, 2008
 · 
1 min read
Lone Star Bio
Risk of Breast Cancer Relapse Can Linger, University of Texas M. D. Anderson Cancer Center Study
August 13, 2008
 · 
1 min read
Bio NC
‘Lost Tribe’ Of Clinician-scientists: Medical Doctors Who Do Research Could Be A Dying Breed
August 12, 2008
 · 
1 min read
Lone Star Bio
New Therapy Freezes Out Esophageal Cancers; Cryoablation Attractive Option For Older Patients With Other Medical Issues, University of Texas Southwestern Medical Center Team Says
August 11, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens
February 18, 2026
 · 
4 min read
Press Releases
Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 18, 2026
 · 
3 min read
Press Releases
Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)
February 18, 2026
 · 
10 min read
Press Releases
Medicenna Therapeutics Announces Participation in Upcoming Conferences
February 18, 2026
 · 
4 min read
Press Releases
Natera to Report its Fourth Quarter and Full Year Results on February 26, 2026
February 17, 2026
 · 
1 min read
Press Releases
Diakonos Oncology Announces Study to Continue after First DSMB Safety Review of DOC1021 in Phase 2 GBM Study
February 17, 2026
 · 
3 min read
Press Releases
Clinical Utility of bioAffinity Technologies’ CyPath® Lung Test Demonstrated in Real-World Case Study
February 17, 2026
 · 
5 min read
Press Releases
Moleculin Announces Notice of Allowance for Japanese Patent Covering Annamycin
February 17, 2026
 · 
5 min read
Press Releases
CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company’s Recently Initiated Strategic Transformation
February 17, 2026
 · 
7 min read
Press Releases
Sanara MedTech Inc. to Participate in the TD Cowen 46th Annual Health Care Conference on March 3rd
February 17, 2026
 · 
3 min read
Load More